<?xml version="1.0" encoding="UTF-8"?>
<ref id="B217-marinedrugs-18-00627">
 <label>217.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Szyrwiel</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Pap</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Malinka</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Szewczuk</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Kotynia</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Brasun</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Interactions of Anti-Parkinson Drug Benserazide with Zn(II), Cu(II), Fe(II) Ions</article-title>
  <source>J. Pharm. Biomed. Anal.</source>
  <year>2013</year>
  <volume>76</volume>
  <fpage>36</fpage>
  <lpage>43</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jpba.2012.11.032</pub-id>
  <pub-id pub-id-type="pmid">23291441</pub-id>
 </element-citation>
</ref>
